News
Switzerland’s basic health insurance started reimbursing part of the cost of Wegovy, a weight-loss drug developed by Danish pharmaceutical giant Novo Nordisk. The decision has led to ...
22m
Dear Media on MSNExploring The Body Positivity-to-Ozempic Pipeline: How Did We Get Here? - Dear MediaScroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...
Researchers have demonstrated that renal impairment highly increases the risk of vertebral fracture among type 2 diabetes ...
Opening up in a recent podcast episode, Katie Price disclosed that a "lot's gonna change" for her son, Harvey, who is set to move from college to "independent living" ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Scientists are starting to learn that highly processed foods can have certain effects on your body that may make sticking to ...
A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Just over a month before police found him dead in his car in Frisco, Texas, Michael Rigsby, a beloved 26-year-old musician ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results